Evidence map›Paper›PMID 37830578›Full record

ArticleCells2023

Exploration of SUMO2/3 Expression Levels and Autophagy Process in Fragile X-Associated Tremor/Ataxia Syndrome: Addressing Study Limitations and Insights for Future Research.

Maria Isabel Alvarez-Mora, Glòria Garrabou, Laura Molina-Porcel, Ruben Grillo-Risco, Francisco Garcia-Garcia, Tamara Barcos, Judith Cantó-Santos, Laia Rodriguez-Revenga

Open access · goldAbstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Maria Isabel Alvarez-MoraBiochemistry and Molecular Genetics Department, Hospital Clinic of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0003-3788-8915
Glòria GarrabouCIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III, 08036 Barcelona, Spain.ORCID 0000-0001-8973-9933
Laura Molina-PorcelFundacio de Recerca Clínic Barcelona-Institut d'Investigacions Biomediques August Pi i Sunyer (FRCB-IDIBAPS), 08036 Barcelona, Spain.ORCID 0000-0003-4068-8578
Ruben Grillo-RiscoBioinformatics and Biostatistics Unit, Principe Felipe Research Center (CIPF), 46012 Valencia, Spain.
Francisco Garcia-GarciaBioinformatics and Biostatistics Unit, Principe Felipe Research Center (CIPF), 46012 Valencia, Spain.
Tamara BarcosBiochemistry and Molecular Genetics Department, Hospital Clinic of Barcelona, 08036 Barcelona, Spain.
Judith Cantó-SantosCIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III, 08036 Barcelona, Spain.
Laia Rodriguez-RevengaBiochemistry and Molecular Genetics Department, Hospital Clinic of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-6332-3929
Instituto de Salud Carlos III · ESCentro de Investigacion Principe Felipe · ESHospital Clínic de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder that appears in adult

Indexed as

Fragile X SyndromeTremorAdultAtaxiaAutophagyFragile X Messenger Ribonucleoprotein 1HumansSmall Ubiquitin-Related Modifier ProteinsUbiquitinFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1Small Ubiquitin-Related Modifier ProteinsSUMO2 protein, humanUbiquitinautophagyFMR1 premutationFXTASp62SUMO2/3SUMOylation

Identifiers

PMID37830578
PMCPMC10571773
OpenAlexW4387101513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.